Results 211 to 220 of about 56,147 (276)

Neuroimaging of affective symptoms in Lewy body dementia: A systematic review

Mullis N, Wright LM.
europepmc   +1 more source

Reconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes. [PDF]

Alzheimers Dement
Liu S, Yang S, Sui Y.
europepmc   +1 more source

Early functional changes in lewy body dementia: roles of dynamics, locus coeruleus, and compensation. [PDF]

Alzheimers Res Ther
Mitterová K, Výtvarová E, Kovářová A, Lamoš M, Fousek J, Rektorová I.   +5 more
europepmc   +1 more source

Lewy Body Dementia Research in Latin America: A Scoping Review. [PDF]

Mov Disord Clin Pract
Cano-Gutiérrez C, Salazar-Londoño S, Botero-Rodriguez F, Páez-García S, Giraldo S, Santacruz-Escudero JM, Aarsland D, Borda MG, COL‐DLB.   +8 more
europepmc   +1 more source

Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson\u27s and Alzheimer\u27s diseases [PDF]

, 2016
Cairns, Nigel J, et al,
core   +1 more source

Alpha-synuclein seeding amplification assays in Lewy body dementia: a brief review. [PDF]

Mol Neurodegener
Bregendahl M, Kaya ZB, Singer W, McLean PJ.   +3 more
europepmc   +1 more source

Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes. [PDF]

Alzheimers Dement
Hannaway N, Zarkali A, Bhome R, Dobreva I, Thomas GEC, Veleva E, Belio IG, Tucker K, Heslegrave A, Zetterberg H, Weil RS.   +10 more
europepmc   +1 more source

Reply: Reconsidering white matter vulnerability and biomarker interpretation across Lewy body dementia subtypes. [PDF]

Alzheimers Dement
Hannaway N, Zarkali A, Bhome R, Dobreva I, Thomas GE, Veleva E, Belio IG, Tucker K, Heslegrave A, Zetterberg H, Weil RS.   +10 more
europepmc   +1 more source